INPLASY202090091

Comparison of the cardiorenal benefits from SGLT2 inhibitors for patients with different underlying disease: a meta-analysis of cardiovascular and renal outcome trials

Keywords: SGLT2 inhibitors; type 2 diabetes; chronic heart failure; chronic kidney disease; cardiovascular death; kidney function progression.

Download PDF - 202090091